UVA Cancer Center researchers identify two subtypes of blood cancer
Researchers at UVA Cancer Center have identified two alternative subtypes of acute myeloid leukemia and a way to identify high-risk patients.
Researchers at UVA Cancer Center have identified two alternative subtypes of acute myeloid leukemia and a way to identify high-risk patients.
This is certainly different sort of letter. I hope you will indulge me for a few minutes of your time. It recounts my love of UVA hoops, my childhood memories in Charlottesville, and my fight against cancer. As bizarre as it may seem, they all go hand in hand.
Dr. Timothy N. Showalter has been selected as the 2023 Edlich-Henderson Innovator of the Year by the University of Virginia.
A new report shows that high levels of radon, the second leading cause of lung cancer, is found in approximately 25 percent of homes in Virginia.
Proton radiation therapy is a groundbreaking nonsurgical advanced radiation technology clinically proven to precisely treat tumors.
A new decision-making aid, developed by experts at UVA Health and their collaborators, helps women at high risk of breast cancer.
VCU Massey Comprehensive Cancer Center is accepting applications for 2024 seed grants through January 18, 2024.
VCU Massey Comprehensive Cancer Center deployed two mobile health vans in fall 2023 to deliver cancer education to underserved communities.
A clinical trial aims to evaluate the safety of treating oral cancers in dogs, and potentially humans, with a device that delivers chemotherapy directly to the tumor.
Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a new treatment for patients with pancreatic cancer.
We don’t take press releases or official statements as the final word. Digging in to get the whole story takes time and resources.